[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340962-105":59,"doc-detail-340962-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ucp2-promotes-nsclc-proliferation-and-glycolysis-via-the-mtorhif-1-signaling","UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF-1α signaling","","Metabolic disturbance drives malignancy and therapy resistance in cancers, making metabolic signaling a promising therapeutic direction. This study examines how uncoupling protein 2 (UCP2) regulates tumor growth and metabolic reprogramming in non-small cell lung cancer (NSCLC). qRT-PCR assesses UCP2 expression in NSCLC tissues and cell lines, while functional assays test proliferation and glycolysis. Western blotting verifies regulation of mTOR and HIF-1α signaling, linking UCP2 to NSCLC progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ucp2-promotes-nsclc-proliferation-and-glycolysis-via-the-mtorhif-1-signaling/340962/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ucp2-promotes-nsclc-proliferation-and-glycolysis-via-the-mtorhif-1-signaling/340962.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study investigate about UCP2 in NSCLC?","Question",{"text":112,"@type":113},"How UCP2 influences NSCLC tumor growth and metabolic reprogramming, specifically through mTOR/HIF-1α signaling.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is UCP2 expression measured in the study?",{"text":117,"@type":113},"UCP2 expression in NSCLC tissues and cell lines is detected using qRT-PCR.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the main functional effects of inhibiting UCP2?",{"text":121,"@type":113},"Silencing UCP2 suppresses NSCLC cell proliferation and glycolysis capacity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340962,1790510810,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","DOI: 10. 1002/cam4 .6938  \nRESEAR CH ARTICLE  \nUCP2 promotes NSCLC proliferation and glycolysis via themTOR/HIF-1α signaling  \nCailu Song1 | Qing Liu1 | Jing Qin2 | Lingrui Liu1 | Zhigang Zhou2 | Han Yang1   \n1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China  \n2Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital Of Changde City), Changde, China  \nCorrespondence  \nZhigang Zhou, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, 415003, China. [Email:](Email: nhzhouzhigang@sina.com)[ nhzhouzhigang@sina.com](Email: nhzhouzhigang@sina.com)  \nHanYang, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. [Email:](Email: yanghan@sysucc.org.cn)[ yanghan@sysucc.org.cn](Email: yanghan@sysucc.org.cn)  \nFunding information  \nThe science and technology Program of Guangzhou, Grant/Award Number:  \n202102080084  \n1 | INTRODUCTION  \nAbstract  \nBackground: Metabolic disturbance is a hallmark of cancers. Targeting key metabolic pathways and metabolism-related molecular could be a potential therapeutic approach. Uncoupling protein 2 (UCP2) plays a pivotal part in the malignancy of cancer and its capacity to develop resistance to pharmaceutical interventions. However, it is unclear about the mechanism of how UCP2 acts in the tumor growth and metabolic reprogramming process in non-small cell lung cancer (NSCLC) .  \nMethods: Here, we conducted qRT-PCR to investigate the expression of UCP2 in both NSCLC tissues and cell lines. Subsequent functional studies including colony formation assay, CCK-8 assay, and glycolysis assay were conducted to investigate the functions of UCP2 in NSCLC. The regulatory mechanism of UCP2 toward the mammalian target of rapamycin (mTOR) and hypoxia-inducible factor-1 alpha (HIF-1α) signaling in NSCLC was confirmed through western blotting.  \nResults: We observed a significant upregulation of UCP2 in both NSCLC tissues and cell lines. The increased expression of UCP2 has a strong association with a worse outlook. Silencing UCP2 remarkably dampened NSCLC cell proliferation and glycolysis capacities. Mechanically, UCP2 promoted NSCLC tumorigenesis partially via regulating the mTOR/HIF-1α axis.  \nConclusion: Taken together, we explored the functions as well as the mechanisms ofthe UCP2/mTOR/HIF-1α axis in NSCLC progression, uncovering potential biological signatures and targets for NSCLC treatment.  \nKEYWORDS  \nglycolysis, HIF-1α, mTOR, NSCLC, proliferation, UCP2  \nthere has been remarkable revolutionary progress made in NSCLC management, especially the progress in precision  \nNon-small cell lung cancer (NSCLC) is recognized asan aggressive and deadly malignancy globally. Recently,  \nmedicine and targeting therapy.1,2 Though the advances in management of NSCLC have significantly improved the  \n\n| Cailu Song, Qing Liu, and Jing Qin contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. |\n\nCancer Medicine. 2024;13:e6938 .  \n[https://doi.org/10.1002/cam4.6938](https://doi.org/10.1002/cam4.6938)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 9  \nscreening, diagnosis, and treatment of NSCLC, there are still cases where the outlook for NSCLC patients remains unfavorable.3,4  \nMetabolism reprogramming, as a hallmark of cancer, is vital for cancer cells to sustain uncontrolled growth and survival under stressful conditions.5 In NSCLC, glucose and mitochondrial metabolism play vital roles ","cbCaikuWf5IaQpGn","https://ap.wps.com/l/cbCaikuWf5IaQpGn","pdf",2658733,"English","# Introduction\n# Methods\n## Data collection","[{\"question\":\"What question does the study investigate about UCP2 in NSCLC?\",\"answer\":\"How UCP2 influences NSCLC tumor growth and metabolic reprogramming, specifically through mTOR/HIF-1α signaling.\"},{\"question\":\"How is UCP2 expression measured in the study?\",\"answer\":\"UCP2 expression in NSCLC tissues and cell lines is detected using qRT-PCR.\"},{\"question\":\"What are the main functional effects of inhibiting UCP2?\",\"answer\":\"Silencing UCP2 suppresses NSCLC cell proliferation and glycolysis capacity.\"}]","UCP2 promotes NSCLC proliferation and glycolysis via the mTOR/HIF-1α signaling | PDF",1790039718,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0826e55e0cacbfae576e878bb5c92fb9.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd22e8bbe90a670c8f5610eb7d4caade.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed505f6e051351e5368631efa8c0d154.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d04457b603b1a18029f516221122847.webp",980,1287]